The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
Takeshita
K
K
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Arakawa
K
K
Okamoto
M
M
Akioka
K
K
Fujiwara
I
I
Kobayashi
K
K
Imanishi
J
J
Oka
T
T
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D000990:Antithrombin III / Q000494:pharmacology*; D015415:Biomarkers; D003165:Complement System Proteins / Q000032:analysis; D004285:Dogs; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D013552:Swine; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D000925:Anticoagulants; D015415:Biomarkers; D007166:Immunosuppressive Agents; D000990:Antithrombin III; D003165:Complement System Proteins